DNA-drug Conjugates for Site-specific Delivery in Anti-cancer Therapy

E-ISSN： 1875-6913|14|2|68-73

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.14, Iss.2, 2017-04, pp. : 68-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancing the Site-Specific Targeting of Macromolecular Anticancer Drug Delivery Systems

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 229-235

Bentham Science Publishers

Access to resources Recommend Favorite

Niosomal Gel for Site-Specific Sustained Delivery of Anti-Arthritic Drug: In Vitro-In Vivo Evaluation

Current Drug Delivery, Vol. 4, Iss. 4, 2007-10 ,pp. : 276-282

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 963-981

Bentham Science Publishers

Access to resources Recommend Favorite

Drug delivery systems: anticancer prodrugs and their polymeric conjugates

By Greenwald R.B.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. : 601-609

Informa Healthcare

Access to resources Recommend Favorite

Lauroyldextran and crosslinked galactomannan as coating materials for site-specific drug delivery to the colon

By Hirsch S. Binder V. Schehlmann V. Kolter K. Bauer K.H.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 47, Iss. 1, 1999-01 ,pp. : 61-71

Elsevier

Access to resources Recommend Favorite